PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
21-Oct-2025 Systematic Review of 15 Studies Focused on Epidemiology and Antimicrobial Resistance of Pneumococcal Serotypes Covered by CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) in U.S. Adults Businesswire
21-Oct-2025 Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated Offerings Businesswire
21-Oct-2025 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
21-Oct-2025 Meteor Biotech launches in Europe with first deployment of spatial biology platform CosmoSort at VIB in Belgium Andrew Lloyd Associates
21-Oct-2025 IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation Businesswire
21-Oct-2025 Atom Therapeutics to Present Positive Data from Clinical Trials of Its Lead Novel Oral Drugs for Chronic Gout and Acute Gout Flares at ACR Convergence 2025 Businesswire
21-Oct-2025 Welnax Lumbar Relief Pro Reviews: Don't Buy Till You've Read This! ACCESS Newswire
21-Oct-2025 Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule Businesswire
21-Oct-2025 MDaudit Spotlights the Vital Role of Health Information Professionals in Today's Evolving Healthcare Landscape ACCESS Newswire
21-Oct-2025 Enamine contributes to the discovery of promising broad-spectrum coronavirus antiviral Businesswire
21-Oct-2025 Medtronic and DASI Simulations Partner to Advance the Future of TAVR Through Predictive Modeling and Personalized Planning ACCESS Newswire
21-Oct-2025 Debuting the "The Power of a Smile" Scholarship ACCESS Newswire
21-Oct-2025 Results of Nanoform Collaborative Study to be Presented at the 2025 Partnership Opportunities in Drug Delivery (PODD) Summit Nanoform
21-Oct-2025 Iksuda presents encouraging IKS014 Phase 1 data at ESMO Iksuda
21-Oct-2025 Lundbeck and Contera Pharma announce research collaboration to advance RNA-targeting medicines for serious neurological conditions Lundbeck, Contera Pharma
21-Oct-2025 Faron Pharmaceuticals Ltd: Holding(s) in Company ACCESS Newswire
21-Oct-2025 Clean Jeju Green Tea Cooperative ‘Sumang’ Accelerates R&D Efforts to Develop Functional Biomaterials from Jeju’s Natural Resources Businesswire
21-Oct-2025 Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus AstraZeneca
21-Oct-2025 Brainomix e-Lung Enables Earlier Detection of Progressive Pulmonary Fibrosis, New Study Shows Brainomix
21-Oct-2025 Subcutaneous RYBREVANT®▼(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer Johnson & Johnson